SLU-PP-332
An orally-available ERR agonist, studied in exercise-mimetic and mitochondrial-biogenesis research, supplied as 30 tablets.
Laboratory Spec Sheet
Reagent Synthesis Profile
SLU-PP-332 is a small molecule that acts as a pan-agonist of the estrogen-related receptors (ERRs), a class of nuclear receptors involved in mitochondrial biogenesis. It has attracted research interest as an orally-active "exercise mimetic" candidate in metabolic studies.
Unlike our peptide vials, SLU-PP-332 is supplied as 30 oral tablets at 1mg each, reflecting its use as a small-molecule compound rather than an injectable peptide.
Each batch is independently tested for identity and purity before packaging.
Product FAQ
Why tablets instead of a vial?＋
SLU-PP-332 is an orally-available small molecule, so it is supplied as tablets rather than a lyophilized injectable vial.
Does this need bacteriostatic water?＋
No — tablets require no reconstitution.
